Insider Transactions by Klassen Preston

Symbol CompanyOwnerRelationshipDateTransactionCost# SharesValue ($)Total SharesFiling
MTCRMetacrine, Inc.Klassen PrestonDirectorMar 23, 2023Option Exercise$0.47842,211395,8391,384,116Mar 24, 2023, 12:35 PM
MTCRMetacrine, Inc.Klassen PrestonPresident & CEOJan 26, 2023Sale$0.41380,605157,266541,905Jan 27, 2023, 04:42 PM
MTCRMetacrine, Inc.Klassen PrestonPresident & CEOApr 19, 2022Sale$0.5044,74822,472923,683Apr 20, 2022, 04:25 PM
MTCRMetacrine, Inc.Klassen PrestonPresident & CEOMay 20, 2021Buy$3.6420,54774,69220,547May 20, 2021, 06:55 PM
ARNAARENA PHARMACEUTICALS INCKlassen PrestonEVP and CMOOct 14, 2019Option Exercise$47.322,309109,2623,991Oct 16, 2019, 08:20 PM
ARNAARENA PHARMACEUTICALS INCKlassen PrestonEVP and CMOJan 07, 2019Sale$28.4032,000908,66616,000Jan 08, 2019, 09:04 PM
ARNAARENA PHARMACEUTICALS INCKlassen PrestonEVP and CMOJan 08, 2019Option Exercise$29.556,000177,3003,000Jan 08, 2019, 09:04 PM
OREXOrexigen Therapeutics, Inc.Klassen PrestonEVP, Global DevelopmentMay 30, 2015Option Exercise$4.171,8607,7565,990Feb 04, 2016, 12:06 PM
OREXOrexigen Therapeutics, Inc.Klassen PrestonEVP, Global DevelopmentNov 30, 2015Option Exercise$2.034,1708,46510,160Feb 04, 2016, 12:06 PM
OREXOrexigen Therapeutics, Inc.Klassen PrestonSVP, Head Global DevelopmentNov 28, 2014Option Exercise$4.921,5427,5874,130Feb 05, 2015, 05:32 PM
OREXOrexigen Therapeutics, Inc.Klassen PrestonSVP, Head Global DevelopmentMay 30, 2014Option Exercise$5.251,3186,9202,588Feb 05, 2015, 05:32 PM
OREXOrexigen Therapeutics, Inc.Klassen PrestonSVP, Head Global DevelopmentNov 29, 2013Option Exercise$5.341,2706,7821,270Feb 11, 2014, 07:33 AM
OREXOrexigen Therapeutics, Inc.Klassen PrestonSVP, Head Global DevelopmentJul 25, 2013Option Exercise$4.41142,458628,24071,229Jul 29, 2013, 07:49 PM
OREXOrexigen Therapeutics, Inc.Klassen PrestonSVP, Head Global DevelopmentMay 28, 2013Option Exercise$4.4357,542255,11828,771May 30, 2013, 05:38 PM